Schedule 13G ownership disclosure

CLEARSIDE BIOMEDICAL INC

Security class unavailable · CUSIP: 185063104

Event date: 2016-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,087,448
Percent of class
10.6500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-16-001189
Form type
SC 13G
Filer
Clearside Biomedical, Inc.
CIK
CIK 1539029
Filed
Jul 11, 2016
Reporting period
Jun 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub